BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27342844)

  • 1. Diacylglycerol Kinase ζ Is a Target To Enhance NK Cell Function.
    Yang E; Singh BK; Paustian AM; Kambayashi T
    J Immunol; 2016 Aug; 197(3):934-41. PubMed ID: 27342844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diacylglycerol kinase ζ inhibitor ASP1570 augments natural killer cell function.
    Okumura M; Yokoyama Y; Yoshida T; Okada Y; Takizawa M; Ikeda O; Kambayashi T
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111145. PubMed ID: 37935092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases.
    Riese MJ; Wang LC; Moon EK; Joshi RP; Ranganathan A; June CH; Koretzky GA; Albelda SM
    Cancer Res; 2013 Jun; 73(12):3566-77. PubMed ID: 23576561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced T cell responses due to diacylglycerol kinase zeta deficiency.
    Zhong XP; Hainey EA; Olenchock BA; Jordan MS; Maltzman JS; Nichols KE; Shen H; Koretzky GA
    Nat Immunol; 2003 Sep; 4(9):882-90. PubMed ID: 12883552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling.
    Joshi RP; Schmidt AM; Das J; Pytel D; Riese MJ; Lester M; Diehl JA; Behrens EM; Kambayashi T; Koretzky GA
    Sci Signal; 2013 Nov; 6(303):ra102. PubMed ID: 24280043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diacylglycerol Kinase ζ Limits Cytokine-dependent Expansion of CD8
    Andrada E; Liébana R; Merida I
    EBioMedicine; 2017 May; 19():39-48. PubMed ID: 28438506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diacylglycerol kinase zeta negatively regulates CXCR4-stimulated T lymphocyte firm arrest to ICAM-1 under shear flow.
    Lee D; Kim J; Beste MT; Koretzky GA; Hammer DA
    Integr Biol (Camb); 2012 Jun; 4(6):606-14. PubMed ID: 22546945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased diacylglycerol metabolism enhances ERK activation and augments CD8+ T cell functional responses.
    Riese MJ; Grewal J; Das J; Zou T; Patil V; Chakraborty AK; Koretzky GA
    J Biol Chem; 2011 Feb; 286(7):5254-65. PubMed ID: 21138839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominant contribution of DGKζ over DGKα in the control of PKC/PDK-1-regulated functions in T cells.
    Ávila-Flores A; Arranz-Nicolás J; Andrada E; Soutar D; Mérida I
    Immunol Cell Biol; 2017 Jul; 95(6):549-563. PubMed ID: 28163304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diacylglycerol kinase ζ (DGKζ) and Casitas b-lineage proto-oncogene b-deficient mice have similar functional outcomes in T cells but DGKζ-deficient mice have increased T cell activation and tumor clearance.
    Wesley EM; Xin G; McAllister D; Malarkannan S; Newman DK; Dwinell MB; Cui W; Johnson BD; Riese MJ
    Immunohorizons; 2018 Apr; 2(4):107-118. PubMed ID: 30027154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCR signaling intensity controls CD8+ T cell responsiveness to TGF-β.
    Arumugam V; Bluemn T; Wesley E; Schmidt AM; Kambayashi T; Malarkannan S; Riese MJ
    J Leukoc Biol; 2015 Nov; 98(5):703-12. PubMed ID: 26153417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diacylglycerol kinase ζ limits IL-2-dependent control of PD-1 expression in tumor-infiltrating T lymphocytes.
    Arranz-Nicolás J; Martin-Salgado M; Rodríguez-Rodríguez C; Liébana R; Moreno-Ortiz MC; Leitner J; Steinberger P; Ávila-Flores A; Merida I
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33246984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Ly49H Receptor Engagement
    Key PN; Germino J; Yang L; Piersma SJ; Tripathy SK
    Front Immunol; 2019; 10():1692. PubMed ID: 31396217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals.
    Arranz-Nicolás J; Ogando J; Soutar D; Arcos-Pérez R; Meraviglia-Crivelli D; Mañes S; Mérida I; Ávila-Flores A
    Cancer Immunol Immunother; 2018 Jun; 67(6):965-980. PubMed ID: 29572701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diacylglycerol kinase ζ limits B cell antigen receptor-dependent activation of ERK signaling to inhibit early antibody responses.
    Wheeler ML; Dong MB; Brink R; Zhong XP; DeFranco AL
    Sci Signal; 2013 Oct; 6(297):ra91. PubMed ID: 24129701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
    Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
    Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired degranulation but enhanced cytokine production after Fc epsilonRI stimulation of diacylglycerol kinase zeta-deficient mast cells.
    Olenchock BA; Guo R; Silverman MA; Wu JN; Carpenter JH; Koretzky GA; Zhong XP
    J Exp Med; 2006 Jun; 203(6):1471-80. PubMed ID: 16717114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative control of diacylglycerol kinase ζ-mediated inhibition of T cell receptor signaling by nuclear sequestration in mice.
    Xie D; Zhang S; Chen P; Deng W; Pan Y; Xie J; Wang J; Liao B; Sleasman JW; Zhong XP
    Eur J Immunol; 2020 Nov; 50(11):1729-1745. PubMed ID: 32525220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention.
    Prinz PU; Mendler AN; Brech D; Masouris I; Oberneder R; Noessner E
    Int J Cancer; 2014 Oct; 135(8):1832-41. PubMed ID: 24615391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia.
    Jing W; Gershan JA; Holzhauer S; Weber J; Palen K; McOlash L; Pulakanti K; Wesley E; Rao S; Johnson BD; Riese MJ
    Cancer Res; 2017 Oct; 77(20):5676-5686. PubMed ID: 28916658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.